Skip to main content
. 2016 Oct-Dec;19(4):626–637. doi: 10.4103/0971-9784.191576

Table 1.

Description of included studies

Author(s) Title Year of publication Type of study Number of patients Inclusion criteria Primary outcome Type of antiplatelet drug used Severity scoring Timing of APT Duration of maximum follow-up Definition of ALI/ARDS Definition of sepsis
Winning et al.[35] Antiplatelet drugs and outcome in severe infection: Clinical impact and underlying mechanisms 2009 Observational 224 Patients who were admitted to the hospital for CAP Need for treatment in ICU Length of hospital stay Aspirin, clopidogrel SOFA 2.95±2.03 (control) versus 2.74±1.18 (APT) Patients on APT for at least 6 months before admission 28 days
Winning et al.[34] Antiplatelet drugs and outcome in mixed admissions to an ICU 2010 Observational 615 Patients admitted to the ICU within 24 h after arrival to the hospital Death during ICU treatment or discharge from ICU Aspirin, clopidogrel APACHE II: 19 (13-19) (control) versus 25 (19-32) (APT) Patients on APT before admission Duration of ICU stay
Erlich et al.[25] Prehospitalization APT is associated with a reduced incidence of ALI 2011 Observational 161 Age>18 years+at least one risk factor for ALI (high-risk trauma, aspiration, sepsis, shock, pneumonia, and pancreatitis) Development of ALI or ARDS during hospitalization Aspirin, clopidogrel, ticlopidine, cilostazol, dipyridamole, anagrelide, persantine APACHE III: 39 (27-54) (control) versus 46 (34-57) (APT) Patients on APT before admission American- European Consensus Conference criteria[40]
Lösche et al.[50] Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients? 2012 Observational 224 Patients admitted to the hospital with CAP Length of hospital stay Admission to ICU Aspirin, ticlopidine, clopidogrel SOFA odds ratio 0.19 (0.04-0.87) Patients on APT for at least 6 months before admission Duration of hospital stay
Lösche et al.[50] Do Aspirin and other antiplatelet drugs reduce the mortality in critically ill patients? 2012 Observational 834 ICU admission for severe sepsis or septic shock ICU mortality Aspirin APACHE II: 22.6±9.2 (control) versus 24.1±8.3 (APT) Duration of ICU stay
Eisen et al.[24] Acetylsalicylic acid usage and mortality in critically ill patients with the SIRS and sepsis 2012 Observational 2890 Patients admitted to the ICU with SIRS Hospital mortality Aspirin APACHE II: 17.78 (control) versus 17.47 (APT) Patients on APT in the 24 h period at time of detection of SIRS America College of Chest Physicians/Society of Critical Care Medicine Consensus Conference criteria[48]
Losche et al.[29] Association of prehospitalization aspirin therapy and ALI: results of a multicenter international observational study of at-risk patients 2012 Observational 3855 Admission to the hospital with the presence of at least one major risk factor for ALI and age>18 years.(aspiration, pneumonia, sepsis, shock, pancreatitis, high-risk trauma, or high-risk surgery) Development of ALI/ARDS during hospitalization Aspirin APACHE II: 9 (5-14) (control) versus 12 (8-16) (APT) Documentation of use or administration of APT at time of hospital admission Duration of hospital stay American- European Consensus Conference criteria[40]
Gross et al.[27] Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of APT in pneumonia and critical illness 2013 Observational 23,882 Patients who received at least 6 consecutive prescriptions of clopidogrel Incidence and severity of pneumonia clopidogrel NA ≥6 prescription claims of APT Duration of hospital stay
Harr et al.[28] APT is associated with decreased transfusion- associated risk of lung dysfunction, multiple organ failure, and mortality in trauma patients 2013 Observational 839 Blunt trauma mechanism, ED arrival within 6 h of injury, ED base deficit>6 mEq/L or ED systolic blood pressure<90 mm Hg, and a blood product transfusion within the first 12 h of ED arrival Lung dysfunction defined by Denver lung dysfunction score of 2 or 3 Denver MOF score (>3) Mortality Aspirin, ticlopidine, clopidogrel NA Patients on APT before trauma 28 days Denver lung dysfunction score Grades 2 or 3, which corresponds to PaO2:FiO2 ratio<200
Valerio-Rojas et al.[33] Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: A historical cohort study 2013 Observational 651 ≥18 years, diagnosis of severe sepsis or septic shock at the time of ICU admission and use of APT before admission Hospital mortality Aspirin, clopidogrel, ticlopidine, dipyridamole APACHE III: 55 (42-68) (control) versus 57.5 (46-74.8) (APT) Patients on APT at time of ICU admission Duration of hospital stay American- European Consensus Conference criteria[40] America College of Chest Physicians/Society of Critical Care Medicine Consensus Conference criteria[48]
Otto et al.[31] Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock 2013 Observational 886 Only patients with severe sepsis/septic shock and minimum ICU stay of 48 h ICU mortality Discharge from ICU Hospital mortality Aspirin, clopidogrel NA Patient on APT for at least 2 days during ICU stay Duration of hospital stay
Faverio et al.[26] Antiplatelets improve survival among critically ill mechanically ventilated patients 2014 Observational 150 Critically ill mechanically ventilated patients for 1 day or more managed at a tertiary medical ICU Mortality during ICU and hospital stay Aspirin, clopidogrel APACHE II>25 Patient on prehospital or in-hospital APT Duration of hospital stay
Chen et al.[23] Prehospital aspirin use is associated with reduced risk of ARDS in critically ill patients: A propensity- adjusted analysis 2015 Observational 1149 Patient who are 18 years old or older admitted to the medical, surgical, cardiovascular, and trauma ICUs who remained in the ICU for at least 2 days ARDS in first 4 days of ICU stay Aspirin NA Patients on APT before admission Duration of hospital stay American- European Consensus Conference criteria[40] America College of Chest Physicians/Society of Critical Care Medicine Consensus Conference criteria[48]
Tsai et al.[32] Association of prior antiplatelet agents with mortality in sepsis patients: A nationwide population-based cohort study 2015 Observational 683,421 All patients with a first time discharge diagnosis of sepsis In-hospital mortality from sepsis Aspirin, clopidogrel, ticlopidine NA Patients on APT currently or within 30 days before admission ICD 9 code for sepsis
Mazzeffi et al.[30] Preoperative aspirin use and lung injury after aortic valve replacement surgery: A retrospective cohort study 2015 Observational 375 All adult patients having aortic valve replacement surgery with cardiopulmonary bypass Occurrence of ARDS Aspirin NA Patients receiving preoperative APT Berlin definition[67]
Boyle et al.[22] Aspirin therapy in patients with ARDS is associated with reduced ICU mortality: A prospective analysis 2015 Observational 202 All adult patients (>16 years-old) requiring invasive mechanical ventilation ICU mortality Aspirin APACHE II: 18 (13-24) in (control) versus 21 (17-24) (APT) Patients on prehospital APT, in ICU APT or both Duration of hospital stay American- European Consensus Conference criteria[40]
Al Harbi et al.[48] Association between aspirin therapy and the outcome in critically ill patients: A nested cohort study 2016 Observational 763 ≥18-year-old with expected ICU length of stay of >48 h. Patients who were pregnant, had do-not-resuscitate status within 24 h of admission, were terminally ill or admitted to the ICU after cardiac arrest, seizures, liver transplantation, or burn injury were excluded All cause ICU mortality and in-hospital mortality Aspirin APACHE II: 22.9±8.2 (control) versus 26.5±7.2 (APT) Patients who had either continuation of a pre-ICU prescription or a newly prescribed APT in the ICU Duration of ICU stay

CAP: Community-acquired pneumonia, SIRS: Systemic inflammatory response syndrome, APACHE: Acute Physiology and Chronic Health Evaluation, SOFA: Sequential Organ Failure Assessment, APT: Antiplatelet therapy, NA: Not available, ICU: Intensive Care Unit, ALI: Acute lung injury, ARDS: Acute respiratory distress syndrome, ED: Emergency department